- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/44 - Oxidoreductases (1)
Patent holdings for IPC class A61K 38/44
Total number of patents in this class: 1185
10-year publication summary
|
71
|
95
|
104
|
101
|
102
|
116
|
109
|
113
|
126
|
29
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Horizon Therapeutics USA, Inc. | 58 |
22 |
| Translate bio, Inc. | 394 |
14 |
| Exoxemis, Inc. | 25 |
13 |
| The Regents of the University of California | 18943 |
12 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
12 |
| CXL Ophthalmics, LLC | 18 |
11 |
| Modernatx, Inc. | 1181 |
11 |
| Selecta Biosciences, Inc. | 190 |
11 |
| Synlogic Operating Company, Inc. | 115 |
11 |
| President and Fellows of Harvard College | 5792 |
10 |
| Children's Medical Center Corporation | 1780 |
10 |
| North Carolina State University | 1492 |
10 |
| Yale University | 2204 |
10 |
| The Trustees of the University of Pennsylvania | 4122 |
9 |
| Matoke Holdings Limited | 30 |
9 |
| Megmilk Snow Brand Co., Ltd. | 173 |
9 |
| California Institute of Technology | 3884 |
8 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
8 |
| University of Washington | 2157 |
8 |
| Centre National de La Recherche Scientifique | 9632 |
7 |
| Other owners | 970 |